Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -225 | 531 | 793 | 76 | 317 |
| Depreciation Amortization | 173 | 608 | 446 | 282 | 141 |
| Income taxes - deferred | -143 | 458 | 359 | 36 | 153 |
| Accounts receivable | 1,222 | 263 | -650 | 961 | -423 |
| Other Working Capital | -526 | 383 | -1,264 | 220 | -658 |
| Other Operating Activity | -1,152 | 35 | 900 | -773 | 528 |
| Operating Cash Flow | $-650 | $2,278 | $584 | $803 | $57 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -886 | -766 | -416 | -208 |
| Purchase Sale Intangibles | N/A | N/A | -30 | N/A | N/A |
| Other Investing Activity | -67 | 0 | -30 | 0 | 0 |
| Investing Cash Flow | $-67 | $-886 | $-796 | $-416 | $-208 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -134 | -134 | -134 | -134 |
| Common Stock Issued | 154 | 5,440 | 5,544 | 5,544 | 18 |
| Other Financing Activity | 0 | 0 | -104 | -104 | -88 |
| Financing Cash Flow | $154 | $5,306 | $5,306 | $5,306 | $-203 |
| Beginning Cash Position | 9,650 | 2,952 | 2,952 | 2,952 | 2,952 |
| End Cash Position | 9,087 | 9,650 | 8,046 | 8,645 | 2,599 |
| Net Cash Flow | $-563 | $6,698 | $5,094 | $5,694 | $-353 |
| Free Cash Flow | |||||
| Operating Cash Flow | -650 | 2,278 | 584 | 803 | 57 |
| Capital Expenditure | N/A | -886 | -766 | -416 | -208 |
| Free Cash Flow | -650 | 1,392 | -183 | 387 | -150 |